Abstract
Raynaud phenomenon is an episodic ischemia caused by cold, emotional stimuli, or rheumatologic disorders, and is more common in women than men. This article describes the clinical presentation of Raynaud phenomenon and how to diagnose and appropriately treat patients and prevent complications. Research on the use of different pharmacologic interventions for Raynaud phenomenon is ongoing and treatment options are expanding.
MeSH terms
-
Blood Sedimentation
-
Calcium Channel Blockers / therapeutic use*
-
Humans
-
Life Style
-
Phosphodiesterase 5 Inhibitors / therapeutic use*
-
Physical Examination
-
Prostaglandins, Synthetic / therapeutic use*
-
Protective Clothing*
-
Raynaud Disease / diagnosis
-
Raynaud Disease / therapy*
-
Selective Serotonin Reuptake Inhibitors / therapeutic use*
Substances
-
Calcium Channel Blockers
-
Phosphodiesterase 5 Inhibitors
-
Prostaglandins, Synthetic
-
Serotonin Uptake Inhibitors